Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Josef Vormoor

Clinical Co-Investigator and Clinical Director of Haemato-oncology
Josef Vormoor
Josef Vormoor
Josef is pediatric oncologist in the Princess Máxima Center and closely co-principal investigator in the group of Olaf Heidenreich.
Phone +31 (0) 6 50 17 30 51

Josef Vormoor received his research MD from Münster University for his work on childhood AML. He gained further research experience as a postdoc in John Dick’s lab at the Hospital for Sick Children in Toronto, working on normal and leukemic hematopoietic stem cells. He then established his own research group on childhood ALL at the University Children’s Hospital in Münster. In 2006, he moved to Newcastle, first as Professor of Clinical Pediatric Oncology, from 2007 as Sir James Spence Professor of Child Health and since 2013 as Director of the Northern Institute for Childhood Cancer. His research covers mechanism of leukemic stemness, communication of the leukemic cells with their microenvironment and preclinical and early clinical drug development for childhood leukemia. 

  • Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers

    • nov. 2023
    • , et al
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Leukaemia suppressing normal bone marrow – how long does it last?

    • nov. 2023
    • Mauricio Nicolas Ferrao, Blanco, et al
    • Haematologica
  • Survival disparities between children and adolescents and young adults for the major subtypes of non-Hodgkin lymphoma in the Netherlands

    • aug. 2023
    • Maya, Schulpen, et al
    • Haematologica
  • Have we made progress in taking care of adolescents and young adults with cancer?

    • jul. 2023
    • Ivana, Bozovic Spasojevic, et al
    • Tumori
  • Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement

    • mrt. 2023
    • Simon, Bomken, et al
    • Haematologica
View all publications